Harrow, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on September 12, 2019. The registrant is incorporated in Delaware and trades on The NASDAQ Capital Market under the symbol "HROW". The report primarily serves to disclose non-financial corporate presentations and investment holdings.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of events rather than a financial statement.
Material Changes and Events
- Regulation FD Disclosure (Item 7.01): The Company attached a corporate presentation (Exhibit 99.1) used by management at investor conferences.
- Investment in Melt Pharmaceuticals (Item 8.01): The Company disclosed its ownership of 3,500,000 shares of Melt Pharmaceuticals, Inc. ("Melt") common stock. This holding represents approximately 44% of Melt's issued and outstanding equity interests.
- Exhibit Disclosure: A corporate presentation for Melt Pharmaceuticals (Exhibit 99.2) was also attached.
Guidance, Outlook, and Risks
The filing explicitly states that the information contained in the attached presentations (Items 7.01 and 8.01) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into other filings, except as expressly set forth by specific reference. No specific forward-looking guidance, risk factors, or contingencies are detailed within the text of this 8-K form itself.
Investor Verification Checklist
- Verify the content of the attached Harrow Health corporate presentation (Exhibit 99.1) for any forward-looking statements or strategic updates.
- Review the Melt Pharmaceuticals presentation (Exhibit 99.2) to understand the business of the subsidiary in which Harrow holds a 44% stake.
- Confirm the current valuation and liquidity status of the 3,500,000 Melt shares held by Harrow, as this represents a significant portion of the subsidiary's equity.
- Note that the attached presentations are not legally "filed" documents and may not be relied upon in the same manner as audited financial statements.